Genome-Wide Association Meta-Analysis Supports Genes Involved in Valve and Cardiac Development to Associate With Mitral Valve Prolapse.


Journal

Circulation. Genomic and precision medicine
ISSN: 2574-8300
Titre abrégé: Circ Genom Precis Med
Pays: United States
ID NLM: 101714113

Informations de publication

Date de publication:
10 2021
Historique:
pubmed: 1 9 2021
medline: 15 2 2022
entrez: 31 8 2021
Statut: ppublish

Résumé

Mitral valve prolapse (MVP) is a common cardiac valve disease, which affects 1 in 40 in the general population. Previous genome-wide association study has identified 6 risk loci for MVP. But these loci explained only partially the genetic risk for MVP. We aim to identify additional risk loci for MVP by adding data set from the UK Biobank. We also incorporated 434 MVP cases and 4527 controls from the UK Biobank for discovery analyses. Genetic association was conducted using SNPTEST and meta-analyses using METAL. We used Functional Mapping and Annotation of Genome-Wide Association Studies for post-genome-wide association study annotations and Multi-marker Analysis of GenoMic Annotation for gene-based and gene-set analyses. We found Trans-Omics for Precision Medicine imputation to perform better in terms of accuracy in the lower ranges of minor allele frequency below 0.1. Our updated meta-analysis included UK Biobank study for ≈8 million common single-nucleotide polymorphisms (minor allele frequency >0.01) and replicated the association on Chr2 as the top association signal near We report an updated meta-analysis genome-wide association study for MVP using dense imputation coverage and an improved case-control sample. We describe several loci and genes with MVP spanning biological mechanisms highly relevant to MVP, especially during valve and heart development.

Sections du résumé

BACKGROUND
Mitral valve prolapse (MVP) is a common cardiac valve disease, which affects 1 in 40 in the general population. Previous genome-wide association study has identified 6 risk loci for MVP. But these loci explained only partially the genetic risk for MVP. We aim to identify additional risk loci for MVP by adding data set from the UK Biobank.
METHODS
We also incorporated 434 MVP cases and 4527 controls from the UK Biobank for discovery analyses. Genetic association was conducted using SNPTEST and meta-analyses using METAL. We used Functional Mapping and Annotation of Genome-Wide Association Studies for post-genome-wide association study annotations and Multi-marker Analysis of GenoMic Annotation for gene-based and gene-set analyses.
RESULTS
We found Trans-Omics for Precision Medicine imputation to perform better in terms of accuracy in the lower ranges of minor allele frequency below 0.1. Our updated meta-analysis included UK Biobank study for ≈8 million common single-nucleotide polymorphisms (minor allele frequency >0.01) and replicated the association on Chr2 as the top association signal near
CONCLUSIONS
We report an updated meta-analysis genome-wide association study for MVP using dense imputation coverage and an improved case-control sample. We describe several loci and genes with MVP spanning biological mechanisms highly relevant to MVP, especially during valve and heart development.

Identifiants

pubmed: 34461747
doi: 10.1161/CIRCGEN.120.003148
pmc: PMC8530910
mid: NIHMS1730913
doi:

Types de publication

Journal Article Meta-Analysis Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e003148

Subventions

Organisme : Medical Research Council
ID : MC_PC_17228
Pays : United Kingdom
Organisme : NHLBI NIH HHS
ID : R01 HL149696
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL127692
Pays : United States
Organisme : NIGMS NIH HHS
ID : P20 GM103444
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL131546
Pays : United States
Organisme : Medical Research Council
ID : MC_QA137853
Pays : United Kingdom

Références

PLoS Comput Biol. 2015 Apr 17;11(4):e1004219
pubmed: 25885710
Nat Genet. 2019 Jun;51(6):957-972
pubmed: 31152163
Nat Genet. 2016 Oct;48(10):1284-1287
pubmed: 27571263
PLoS Biol. 2011 Jan 18;9(1):e1000582
pubmed: 21267068
Circ Res. 2021 Mar 5;128(5):e84-e101
pubmed: 33508947
Mol Cell Biol. 2004 May;24(10):4241-54
pubmed: 15121845
Nat Protoc. 2010 Sep;5(9):1564-73
pubmed: 21085122
Genome Res. 2012 Sep;22(9):1790-7
pubmed: 22955989
Nat Commun. 2017 Nov 28;8(1):1826
pubmed: 29184056
Bioinformatics. 2015 Mar 1;31(5):782-4
pubmed: 25338720
Nucleic Acids Res. 2019 Jan 8;47(D1):D886-D894
pubmed: 30371827
Nat Genet. 2018 Jan;50(1):6-11
pubmed: 29255261
Proc Natl Acad Sci U S A. 2011 Mar 8;108(10):4006-11
pubmed: 21330551
Nature. 2021 Feb;590(7845):290-299
pubmed: 33568819
Eur Heart J. 2018 Apr 14;39(15):1269-1277
pubmed: 29020406
JAMA. 1995 Sep 13;274(10):813-9
pubmed: 7650805
Curr Top Dev Biol. 2017;122:195-221
pubmed: 28057264
Nat Genet. 2016 Oct;48(10):1279-83
pubmed: 27548312
Nucleic Acids Res. 2004 Jan 1;32(Database issue):D552-6
pubmed: 14681479
Nat Rev Cardiol. 2015 Dec;12(12):689-710
pubmed: 26483167
Bioinformatics. 2011 Nov 15;27(22):3216-7
pubmed: 21965822
Nat Genet. 2019 Jan;51(1):51-62
pubmed: 30578418
Annu Rev Genomics Hum Genet. 2018 Aug 31;19:73-96
pubmed: 29799802
Bioinformatics. 2011 Jun 15;27(12):1739-40
pubmed: 21546393
Ann N Y Acad Sci. 2006 May;1067:37-44
pubmed: 16803968
Nature. 2017 Oct 11;550(7675):204-213
pubmed: 29022597
Dev Dyn. 2000 Sep;219(1):90-5
pubmed: 10974675
Bioinformatics. 2010 Sep 1;26(17):2190-1
pubmed: 20616382
Circ Genom Precis Med. 2019 May;12(5):e002497
pubmed: 31112420
Bioinformatics. 2011 Aug 1;27(15):2156-8
pubmed: 21653522
N Engl J Med. 1999 Jul 1;341(1):1-7
pubmed: 10387935
Nat Genet. 2006 Aug;38(8):904-9
pubmed: 16862161
Bioinformatics. 2010 Sep 15;26(18):2336-7
pubmed: 20634204
PLoS Med. 2015 Mar 31;12(3):e1001779
pubmed: 25826379
Sci Transl Med. 2019 May 22;11(493):
pubmed: 31118289
Nat Genet. 2015 Oct;47(10):1206-11
pubmed: 26301497
Neuroepidemiology. 2003 Nov-Dec;22(6):316-25
pubmed: 14598854
Nat Genet. 2007 Jul;39(7):906-13
pubmed: 17572673
Am Heart J. 2004 Feb;147(2):224-7
pubmed: 14760317
Nat Methods. 2011 Dec 04;9(2):179-81
pubmed: 22138821

Auteurs

Mengyao Yu (M)

PARCC, Inserm, Université de Paris, F-75015, Paris, France (M.Y., S.K., X.J., N.B.-N.).

Sergiy Kyryachenko (S)

PARCC, Inserm, Université de Paris, F-75015, Paris, France (M.Y., S.K., X.J., N.B.-N.).

Stephanie Debette (S)

Bordeaux Population Health Research Center, Inserm Center U1219, University of Bordeaux, France (S.D.).
Department of Neurology, Bordeaux University Hospital, Inserm U1219, France (S.D.).

Philippe Amouyel (P)

University of Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1167 - RID-AGE - Labex DISTALZ - Risk Factors and Molecular Determinants of Aging-Related Disease, Lille, France (P.A.).

Jean-Jacques Schott (JJ)

Université de Nantes, INSERM, CNRS, CHU Nantes, l'institut du thorax, F-44000, France (J.-J.S., T.L.T., C.D.).

Thierry Le Tourneau (T)

Université de Nantes, INSERM, CNRS, CHU Nantes, l'institut du thorax, F-44000, France (J.-J.S., T.L.T., C.D.).

Christian Dina (C)

Université de Nantes, INSERM, CNRS, CHU Nantes, l'institut du thorax, F-44000, France (J.-J.S., T.L.T., C.D.).

Russell A Norris (RA)

Department of Regenerative Medicine and Cell Biology (R.A.N.), Medical University of South Carolina, Charleston, SC.
Department of Medicine (R.A.N.), Medical University of South Carolina, Charleston, SC.

Albert A Hagège (AA)

Assistance Publique - Hôpitaux de Paris, Department of Cardiology, Hôpital Européen Georges Pompidou, France (A.A.H.).

Xavier Jeunemaitre (X)

PARCC, Inserm, Université de Paris, F-75015, Paris, France (M.Y., S.K., X.J., N.B.-N.).

Nabila Bouatia-Naji (N)

PARCC, Inserm, Université de Paris, F-75015, Paris, France (M.Y., S.K., X.J., N.B.-N.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH